Molecular mechanisms of inherited ventricular arrhythmias

Herz

Volumn 27, Issue 8, 2002, Pages 712-739

  Wichter, Thomas ^a   Schulze Bahr, Eric ^b   Eckardt, Lars ^b   Paul, Matthias ^b   Levkau, Bodo ^b   Meyborg, Matthias ^b   Schäfers, Michael ^b   Haverkamp, Wilhelm ^b   Breithardt, Günter ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NONE

Author keywords

Brugada syndrome; Cardiomyopathy; Gene mutation; Ion channel; Long QT syndrome; Sudden death; Tachyarrhythmias; Ventricular tachycardia

Indexed keywords

CATECHOLAMINE; CYTOSKELETON PROTEIN; PLAKOGLOBIN; RYANODINE RECEPTOR; SODIUM CHANNEL;

AUTONOMIC INNERVATION; AUTOSOMAL DOMINANT DISORDER; BRUGADA SYNDROME; GENETIC DISORDER; GENOTYPE PHENOTYPE CORRELATION; HEART OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; KERATOSIS PALMOPLANTARIS; LONG QT SYNDROME; MOLECULAR BIOLOGY; PATHOGENESIS; PATHOLOGICAL ANATOMY; RECEPTOR GENE; REVIEW; SUDDEN DEATH;

DEATH, SUDDEN, CARDIAC; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ION CHANNELS; PHENOTYPE; TACHYCARDIA, VENTRICULAR;

EID: 0036963349     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-002-2436-x     Document Type: Review

References (199)

1. Ackerman MJ. The long QT syndrome: ion channel diseases of the heart. Mayo Clin Proc 1998;73:250-9.
2. Ahmad F, Li D, Karibe A, Gonzalez O, Tapscott T, Hill R, Weilbaecher D, Blackie P, Furey M, Gardner M, Bachinski LL, Roberts R. Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation 1998;98: 2791-5.
3. Akai J, Makita N, Sakurada H, Shirai N, Ueda K, Kitabatake A, Nakazawa K, Kimura A, Hiraoka M. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett 2000;479:29-34.
4. Alings M, Wilde A. Brugada syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999;99:666-73.
5. An RH, Bangalore R, Rosero SZ, Kass RS. Lidocaine block of LQT-3 mutant human Na+ channels. Circ Res 1996;79:103-8.
6. An RH, Wang XL, Kerem B, Benhorin J, Medina A, Goldmit M, Kass RS. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits. Circ Res 1998;83:141-6.
7. Antzelevitch C. The Brugada syndrome: ionic and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001;12:268-72.
8. Antzelevitch C. Sympathetic modulation of the long QT syndrome. Eur Heart J 2002;23:1246-52.
9. Atarashi H, Ogawa S, Harumi K, Sugimoto T, Inoue H, Murayama M, Toyama J, Hayakawa H, for the Idiopathic Ventricular Fibrillation Investigators. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads. J Am Coll Cardiol 2001;37:1916-20.
10. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. K(V)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996;384:78-80.
11. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis? Circulation 1996;94:983-91.
12. Bauce B, Nava A, Ramazzo A, Daliento L, Muriamo M, Basso C, Thiene G, Danieli GA. Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1942-43. Am J Cardiol 2000;85:573-9.
13. Bauce B, Rampazzo A, Basso C, Bagattin A, Daliento L, Tiso N, Turrini P, Thiene G, Danieli GA, Nava A. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death. J Am Coll Cardiol 2002;40:341-9.
14. Beggs AH, Byers TJ, Knoll JH, Boyce FM, Bruns GAP, Kunkel LM. Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosome 1 and 11. J Biol Chem 1992;267:9281-8.
15. Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol 1993;4:356-68.
16. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with class Ia antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without Brugada syndrome. J Cardiovasc Electrophysiol 1999;10:1301-12.
17. Bennett PB, Yazawa K, Makita N, George AIJ. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995;376:683-5.
18. Bezzina C, Veldkamp MW, van den Berg MP, Postma AV, Rook MB, Viersma JW, van Langen IM, Tan-Sindhunata G, Bink-Boelkens MTE, van der Hout AH, Mannens MMAM, Wilde AAM. A single Na+ channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999;85:1206-13.
19. Bornslaeger ES, Godsel LM, Corcoram CM, Park JK, Hatzfeld M, Kowalczyk AP, Green KJ. Plakophilin 1 interferes with plakoglobin binding to desmoplakin, yet together with plakoglobin promotes clustering of desmosomal plaque complexes at cell-cell borders. J Cell Sci 2001;114:727-38.
20. Bowles NE, Ni J, Marcus F, Towbin JA. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2002; 39:892-5.
21. Brooks R, Burgess JH. Idiopathic ventricular tachycardia: a review. Medicine (Baltimore) 1988;67:271-94.
22. Brown RL, Pollock N, Couchman KG, Hodges M, Hutchinson DO, Waaka R, Lynch P, McCarthy TV, Stowell KM. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree. Hum Mol Genet 2000;9:1515-24.
23. 3. Circulation 2002; 105:73-8.
24. 3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-60.
25. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 1992;20:1391-6.
26. Brugada P, Geelen P, Brugada R, Mont L, Brugada J. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:1004-7.
27. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510-5.
28. Bruns HJ, Eckardt L, Vahlhaus C, Schulze-Bahr E, Haverkamp W, Borggrefe M, Breithardt G, Wichter T. Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads. Cardiovasc Res 2002;54:58-66.
29. Calkins H, Lehmann MH, Allman K, Wieland D, Schwaiger M. Scintigraphic pattern of regional cardiac sympathetic innervation in patients with familial long QT syndrome using positron emission tomography. Circulation 1993;87:1616-21.
30. Capetanaki Y, Smith S, Heath JP. Overexpression of the vimentin gene in transgenic mice inhibits normal lens cell differentiation. J Cell Biol 1989;109:1653-64.
31. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-5.
32. Chouabe C, Neyroud N, Guicheney P, Lazdunski M, Romey G, Barhanin J. Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J 1997;16:5472-9.
33. Clancy CE, Rudy Y. Na+ channel mutation that causes both Brugada and long QT syndrome phenotypes. A simulation study of mechanism. Circulation 2002;105:1208-13.
34. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 1998;98:1329-34.
35. Compton SJ, Lux RL, Ramsey MR, Strelich KR, Sanguinetti MC, Green LS, Keating MT, Mason JW. Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation 1996;94:1018-22.
36. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Survivors of out-of-hospital cardiac arrest with apparently normal heart: need for definition and standardized clinical evaluation. Circulation 1997;95:265-72.
37. Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EWA, Houlston RS, Cliff S, Otter MI, Murday VA, Mattu RK, McKenna WJ. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998;97:2049-58.
38. Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G. Right bundle branch block, right precordial ST-segment elevation and sudden death in young people. Circulation 2001;103:710-7.
39. Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomström-Lundqvist C, Wlodarska EK, Fontaine G, Camerini F. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: a multicenter study. J Am Coll Cardiol 1997;30:1512-20.
40. Corrado D, Fontaine G, Marcus FI, McKenna WJ, Nava A, Thiene G, Wichter T. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Circulation 2000;101:e101-6.
41. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathologic correlation in 22 cases. Am J Med 1990;89:588-96.
42. Coumel P, Fidelle J, Lucet V, Attuel P, Bouvrain Y. Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J 1978;40: Suppl:28-37.
43. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803.
44. D'Amati G, Di Gioia CR, Giordano C, Gallo P. Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch Pathol Lab Med 2000;124:287-90.
45. Dalla Volta S, Battagiia G, Zerbini E. "Auricularization" of the right ventricular pressure curve. Am Heart J 1961;61:25-33.
46. Demolombe S, Baro I, Pereon Y, Bliek J, Mohammad-Panah R, Pollard H, Morid S, Mannens M, Wilde A, Barhanin J, Charpentier F, Escande D. A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem 1998;273:6837-43.
47. Di Somma S, Marotta M, Salvatore G, Cudemo G, Cuda G, De Vivo F, Di Benedetto MP, Ciaramella F, Caputo G, de Divitiis O. Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart 2000;84:659-67.
48. Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, Chivoret G, Schwartz K, Coumel P, Guicheney P. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997;96:2778-81
49. Duggal P, Vesely M R, Wattanasirichaigoon D, Villafane J, Kaushik V, Beggs AH. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Circulation 1998;97:142-6.
50. Dumaine R, Wang Q, Keating MT, Hartmann HA, Schwartz PJ, Brown AM, Kirsch GE. Multiple mechanisms of Na+ channel-linked long-QT syndrome. Circ Res 1996;78:916-24.
51. Eckardt L, Bruns HJ, Paul M, Kirchhof P, Schulze-Bahr E, Wichter T, Breithardt G, Borggrefe M, Haverkamp W. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol 2002;13:742-9.
52. Eckardt L, Kirchhof P, Schulze-Bahr E, Rolf S, Ribbing M, Loh P, Bruns HJ, Witte A, Milberg P, Borggrefe M, Breithardt G, Wichter T, Haverkamp W. Electrophysiologic investigation in Brugada syndrome: yield of programmed ventricular stimulation at two ventricular sites with three premature beats. Eur Heart J 2002; 23:1394-1401.
53. Fisher JD, Krikler D, Hallidie-Smith KA. Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing. J Am Coll Cardiol 1999;34:2015-22.
54. Fontaine G, Fontaliran F, Frank R, Chomette G, Grosgogeat I. Causes of sudden death in athletes. Arch Mal Cœur 1989;82: 107-11.
55. Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies. Clinical forms and main differential diagnoses. Circulation 1998;97:1532-5.
56. Fontaine G, Guiraudon G, Frank R, Vedel J, Grosgogeat Y, Cabrol C, Facquet J. Stimulation studies and epicardial mapping in ventricular tachycardia: study of mechanism and selection for surgery. In: Kulbertus HE, ed. Reentrant arrhythmias. Lancaster: MTP, 1977:334-50.
57. Frances R, Rodriguez Benitez AM, Cohen DR. Arrhythmogenic right ventricular dysplasia and anterior polar cataract. Am J Med Genet 1997;73:125-6.
58. Franke WW, Gergt M, Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate filament cage around lipid globules. Cell 1987;49:131-41.
59. Franz WM, Müller OJ, Katus HA. Cardiomyopathies: from genetics to the prospect of treatment. Lancet 2001;358:1627-37.
60. Furuhashi M, Tsuchihashi K, Nagahara D, Hyakukoku M, Ohtomo T, Satoh S, Nishimiya T, Shimamoto K. Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population. Heart 2001;86:161-6.
61. Garg A, Finneran W, Feld GK. Familial sudden cardiac death associated with a terminal QRS abnormality on the surface 12-lead electrocardiogram in the index case. J Cardiovasc Electrophysiol 1998;9:642-7.
62. 123l-meta-iodobenzylguanidine scans in patients with ventricular tachycardia and a "clinically normal" heart. Br Heart J 1993;69:6-13.
63. Gima K, Rudy Y. Ionic current basis of electrocardiographic waveforms: a model study. Circ Res 2002;90:889-96.
64. Gohl K, Feistel H, Weikl A, Bachmann K, Wolf F. Congenital myocardial sympathetic dysinnervation (CMSD) - a structural defect of idiopathic long QT syndrome. PACE 1991;14:1544-53.
65. Grace AA. Brugada syndrome. Lancet 1999;354:445-6.
66. Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman B. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999;33:5-15.
67. Gussak I, Bjerregaard P, Hammill SC. Clinical diagnosis and risk stratification in patients with Brugada syndrome. J Am Coll Cardiol 2001;37:1635-8.
68. Ikeda T, Sakurada H, Sakabe K, Sakata T, Takami M, Tezuka N, Nakae T, Noro M, Enjoji Y, Tejima T, Sugi K, Yamaguchi T. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 2001;37:1628-34.
69. James TN. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994;90:556-73.
70. Kaplan SR, Protonotarios N, Tsatsopoulou A, Fontaine G, Saffitz JE. Diminished myocardial connexin 43 expression and gap junction remodeling in Naxos disease. PACE 2002;24(Part II):525.
71. Kasanuki H, Ohnishi S, Ohtuka M, MatsudaN, Nirei T, Isogai R, Shoda M, Toyoshima Y, Hosoda S. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997;95:2277-85.
72. Kiehn J, Lacerda AE, Wible B, Brown AM. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide. Circulation 1991;94:2572-9.
73. Kiehn J, Wible B, Ficker E, Taglialatela M, Brown AM. Cloned human inward rectifier K+ channel as a target for class III methanesulfonanilides. Circ Res 1995;77:1151-5.
74. Kurita T, Shimizi W, Inagaki M, Sayama K, Taguchi A, Satomi K, Aihara N, Kamakura S, Kobayashi J, Kosakai Y. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002;40:330-4.
75. Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khouri A, Lorber A, Kastner DL, Goldman B, Pras E. Autosomal-recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1P13-21. Circulation 2001;103:2822-7.
76. Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, Levy-Nissenbaum E, Khoury A, Lorber A, Goldman B, Lancet D, Eldar M. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001;37:378-84.
77. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmblatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, Toivonen L, Stephan DA, Kontula K. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485-90.
78. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 1995;91:1512-9.
79. Lerman BB, Dong B, Stein KM, Markowitz SM, Linden J, Catanzaro DF. Right ventruicular outflow tract tachycardia due to a somatic cell mutation in G protein subunit αi2. J Clin Invest 1998;101:2862-8.
80. Leung CL, Green KJ, Liem RKH. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol 2002;12:37-45.
81. Li D, Ahmad F, Gardner MJ, Weilbaecher D, Hill R, Karibe A, Gonzalez O, Tapscott T, Sharratt G, Bachinski LL, Roberts R. The locus of a novel gene responsible for arrhythmogenic right ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10P12-P14. Am J Hum Genet 2000;66:148-56.
82. Li D, Bachinski LL, Roberts R. Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia. Genomics 2001;74:396-401.
83. Li D, Gonzalez O, Bachinski LL, Roberts R. Human protein thyrosine phosphatase-like gene: expression profile, genomic structure, and mutation analysis in patients with ARVD. Gene 2000;256:237-43.
84. Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, Towbin JA, Priori SG, Napolitano C, Robinson JL, Andrews M, Timothy K, Hall WJ. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 1998;97:2237-44.
85. Maisch B. How cardiac cells die - necrosis, oncosis and apoptosis. Herz 1999;24:181-8.
86. Makita N, Shirai N, Nagashima M, Matsuoka R, Yamada Y, Tohse N, Kitabatake A. A de novo missense mutation of human cardiac Na+ channel exhibiting novel molecular mechanisms of long QT syndrome. FEBS Lett 1998;423:5-9.
87. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996;335:1190-6.
88. Marcus FI. Idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 1997;8:1075-83.
89. Marcus FI, Fontaine G. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review. Pacing Clin Electrophysiol 1995;18: 1298-314.
90. Marcus FI, Fontaine G, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y. Right ventricular dysplasia: a report of 24 cases. Circulation 1982;65:384-99.
91. Marks AR. Cardiac intracellular calcium release channels. Circ Res 2000;87:8-11.
92. Marks AR. Clinical implications of cardiac ryanodine receptor/calcium release channel mutations linked to sudden cardiac death. Circulation 2002;106:8-10.
93. Marks AR, Priori SG, Memmi M, Kontula K, Laitinen PJ. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol 2002;190:1-6.
94. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R, Daliento L, Dalla Volta S. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 1989;118:1203-9.
95. Mathews ECJ, Blount AW, Blount AW Jr, Townsend JI. QT prolongation and ventricular arrhythmias, with and without deafness, in the same family. Am J Cardiol 1972;29:702-11.
96. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomström-Lundqvist C, Fontaine G, Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-8.
97. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffrey S, McKenna WJ. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.
98. McRae JR, Wagner GS, Rogers MC, Canent RV. Paroxysmal familial ventricular fibrillation. J Pediatr 1974;84:515-8.
99. Melberg A, Oldfors A, Blomström-Lundqvist C, Stalberg E, Carlsson B, Larsson E, Lidell C, Eeg-Olofsson KE, Wikstrom G, Henriksson G, Dahl N. Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol 1999;46:684-92.
100. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27:1061-70.
101. Monroe MH, Littmann L. Two-year case collection of the Brugada syndrome electrocardiogram pattern at a large teaching hospital. Clin Cardiol 2000;23:849-51.
102. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr, Robinson JL, Benhorin J, Choi S. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991;84:1136-44.
103. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-34.
104. Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002;105:794-9.
105. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, Tunsanga K, Kuasirikul S, Malasit P, Tansupasawadikul S, Tatsanavivat P. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-600.
106. Nava A, Thiene G, Canciani B, Martini B, Daliento L, Buja GF, Fasoli G. Clinical profile of concealed form of arrhythmogenic right ventricular cardiomyopathy presenting with apparently idiopathic ventricular arrhythmias. Int J Cardiol 1992;35:195-206.
107. Nava A, Thiene G, Canciani B, Scognamiglio R, Daliento L, Buja GF, Martini B, Stritoni P, Fasoli G. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol 1988;12:1222-8.
108. Nemec J, Edwars BS, Osborn MJ, Edwards WD. Arrhythmogenic right ventricular dysplasia masquerading as a dilated cardiomyopathy. Am J Cardiol 1999;84:237-9.
109. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, Schwartz K, Guicheney P. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997;15:186-9.
110. Nishikawa T, Ishiyama S, Nagata M, Sakomura Y, Nakazawa M, Momma K, Hiroe M, Kasajima T. Programmed cell death in the myocardium of arrhythmogenic right ventricular cardiomyopathy in children and adults. Cardiovasc Pathol 1999;8:185-9.
111. Norgett EE, Hatsell SJ, Carvajal-Huerta L, Ruiz Cabezas JC, Common J, Purkis PE, Whittock N, Leigh IM, Stevens HP, Kelsell DP. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 2000;9:2761-6.
112. Olson TM, Keating MT. Mapping a cardiomyopathy locus to chromosome 3q22-25. J Clin Invest 1996;97:528-32.
113. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280:750-2.
114. Paul M, Wichter T, Schulze-Bahr E, Breithardt G. Genetics of arrhythmogenic right ventricular cardiomyopathy. In: Schalij MJ, Janse MJ, van Oosterom A, van der Wall EE, Wellens HJJ, eds. 100 years of electrocardiography. Leiden, The Netherlands. The Einthoven Foundation: Einthoven, 2002:265-72.
115. Priori SG, Barhanin J, Hauer RN, Haverkamp W, Jongsma HJ, Kleber AG, McKenna WJ, Roden DM, Rudy Y, Schwartz K, Schwartz PJ, Towbin JA, Wilde AM. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management (parts 1 and 2). Circulation 1999;99:518-28.
116. Priori SG, Barhanin J, Hauer RN, Haverkamp W, Jongsma HJ, Kleber AG, McKenna WJ, Roden DM, Rudy Y, Schwartz K, Schwartz PJ, Towbin JA, Wilde AM. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management (part 3). Circulation 1999;99:674-81.
117. Priori SG, Barhanin J, Hauer RNW, Haverkamp W, Jongsma HJ, Kleber AG, McKenna WJ, Roden DM, Rudy Y, Schwartz K, Schwartz PJ, Towbin JA, Wilde A. Genetic and molecular basis of cardiac arrhythmias. Eur Heart J 1999;20:174-95.
118. Priori SG, Napolitano C, Cantu F, Brown AM, Schwartz PJ. Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res 1996;78:1009-15.
119. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Brignole M, Giordano U, Giovannini U, Menozzi C, Bloise R, Crotti L, Terreni L, Schwartz PJ. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 2000;102: 2509-15.
120. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Naftoli J. Natural history of Brugada syndrome. Insights for risk stratification and management. Circulation 2002;105:1342-7.
121. Priori SG, Napolitano C, Grillo M. Concealed arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular fibrillation? Cardiovasc Res 2001;50:218-23.
122. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FES, Vignati G, Benatar A, DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74.
123. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196-200.
124. Protonotarios N, Tsatsopoulou A, Anastasakis A, Sevdalis E, Mc Koy G, Stratos K, Gatzoulis K, Tentolouris K, Spiliopoulou C, Panagiotakos D, McKenna W, Toutouzas P. Genetype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin. J Am Coll Cardiol 2001;38:1477-87.
125. Protonotarios N, Tsatsopoulou A, Patsourakos P, Alexopoulos D, Gezerlis P, Simitsis S, Scampardonis G. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J 1986;56:321-6.
126. Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 1994;3:959-62.
127. Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Danieli GA. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD 2) maps to chromosome 1q42-q43. Hum Mol Genet 1995;4:2151-4.
128. Rampazzo A, Nava A, Miorin M, Fonderico P, Pope B, Tiso N, Livolsi B, Zimbello R, Thiene G, Danieli GA. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 1997;45:259-63.
129. Remme CA, Wever EFD, Wilde AAM, Derksen R, Hauer RNW. Diagnosis and long-term folllow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur Heart J 2001;22:400-9.
130. Richardson P, McKenna WJ, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-2.
131. Romey G, Attali B, Chouabe C, Abitbol I, Guillemare E, Barhanin J, Lazdunski M. Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity. J Biol Chem 1997;272:16713-6.
132. Rook MB, Alshinawi CB, Groenewegen WA, van Gelder IC, van Ginneken ACG, Jongsma HJ, Mannens MMAM, Wilde AAM. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res 1999;44:507-17.
133. Sanchez Cascos A, Sanchez Pernaute R, Cifuentes S. A child affected bythe Romano-Ward syndrome born of a mother with the Jervell and Lange-Nielsen syndrome. Rev Esp Cardiol 1990; 43:406-7.
134. Sanguinetti MC, Curran ME, Spector PS, Keating MT. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA 1996;93:2208-12.
135. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT. Coassembly of K(v)LQT1 and mink (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996;384:80-3.
136. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995;81:299-307.
137. Sato T, Hata Y, Yamamoto M, Morita H, Mizuo K, Yamanari H, Saito D, Ohe T. Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome. J Cardiovasc Electrophysiol 1995;6:279-82.
138. Schäfers M, Lerch H, Wichter T, Rhodes CG, Lammertsma AA, Borggrefe M, Hermansen F, Schober O, Breithardt G, Camici PG. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol 1998;32:181-6.
139. Schäfers M, Schober O, Lerch H. Cardiac sympathetic neurotransmission scintigraphy. Eur J Nucl Med 1998;25:435-41.
140. Schäfers M, Wichter T, Lerch H, Kuwert T, Schäfers K, Borggrefe M, Breithardt G, Schober O. Cardiac iodine-123-metaiodobenzylguanidine uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med 1999;40:1-5.
141. Schäfers MA, Wichter T, Schäfers KP, Rahman S, Rhodes CG, Lammertsma AA, Lerch H, Knickmeier M, Hermansen F, Schober O, Camici PG, Breithardt G. Pulmonary b-adrenoceptor density in arrhythmogenic right ventricular cardiomyopathy and idiopathic ventricular tachycardia. Basic Res Cardiol 2001;96:91-7.
142. Schnittler HJ, Puschel B, Drenckhahn D. Role of cadherins and plakoglobin in interendothelial adhesion under resting conditions and under shear stress. Am J Physiol 1997;335: H2396-405.
143. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeck M, Wilde AA, Escande D, Mannes MM, Le Marec H. Cardiac conduction defects associate with mutation in SCN5A. Nat Genet 1999;23:20-1.
144. Schulze-Bahr E, Eckardt L, Seidl KH, Seiler P, Wichter T, Breithardt
145. Schulze-Bahr E, Haverkamp W, Wedekind H, Rubie C, Hordt M, Borggrefe M, Assmann G, Breithardt G, Funke H. Autosomal recessive long-QT syndrome (Jervell Lange-Nielsen syndrome) is genetically heterogeneous. Hum Genet 1997;100:573-6.
146. Schulze-Bahr E, Haverkamp W, Wiebusch H, Schulte H, Hördt M, Borggrefe M, Breithardt G, Assmann G, Funke H. Molecular analysis at the Harvey-Ras 1 gene in patients with long-QT syndrome. J Mol Med 1995;73:565-9.
147. Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y, Rubie C, Hördt M, Towbin JA, Borggrefe M, Assmann G, Qu X, Somberg JC, Breithardt G, Oberti C, Funke H. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997; 17:267-8.
148. Schwartz P, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation 1993;88: 782-4.
149. Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantu F, Towbin JA, Keating MT, Hammoude H, Brown AM, Chen LS. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995;92:3381-6.
150. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95.
151. Severini GM, Krajinovic M, Pinamonti B, Sinagra G, Fioretti P, Brunazzi MC, Falaschi A, Camerini F, Giacca M, Mestroni L, and the Heart Muscle Disease Study Group. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 1996;31:193-200.
152. Shalaby FY, Levesque PC, Yang WP, Little WA, Conder ML, Jenkins-West T, Blanar MA. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation 1997;96:1733-6.
153. Shen WK, Edwards WD, Hammill SC, Bailey KR, Ballard DJ, Gersh BJ. Sudden unexpected nontraumatic sudden death in 54 young adults: a 30-year population-based study. Am J Cardiol 1995;76: 148-52.
154. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997;96:2038-47.
155. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998;98:2314-22.
156. Shimizu W, Kurita T, Matsuo K, Suyama K, Aihara N, Kamakura S, Towbin JA, Shimomura K. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. Circulation 1998;97:1581-8.
157. Smits JPP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D, Schulze-Bahr E, LeMarec H, Wilde AAM. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002;40:350-6.
158. Spector PS, Curran ME, Keating MT, Sanguinetti MC. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. Circ Res 1996;78:499-503.
159. Spector PS, Curran ME, Zou AR, Sanguinetti MC. Fast inactivation causes rectification of the IKr channel. J Gen Physiol 1996;107: 611-9.
160. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000;102:1178-85.
161. Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997;336:1562-7.
162. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997;17:338-40.
163. Stokes DL, Wagenknecht T. Calcium transport across the sarcoplasmatic reticulum. Eur J Biochem 2000;267:5274-9.
164. Suzuki H, Torigoe K, Numata O, Yazaki S. Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol 2000;11:1277-80.
165. Swan H, Laitinen PJ. Familial polymorphic ventricular tachycardia - intracellular calcium channel disorder. Card Electrophysiol Rev 2002;6:81-7.
166. Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K, Kere J, Keto P, Kontula K, Toivonen L. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999;34:2035-42.
167. Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995;122:701-14.
168. Tesson F, Donger C, Denjoy I, Berthet M, Bennaceur M, Petit C, Coumel P, Schwartz K, Guicheney P. Exclusion of KCNE1 (IsK) as a candidate gene for Jervell and Lange-Nielsen syndrome. J Mol Cell Cardiol 1996;28:2051-5.
169. Thiene G, Basso C, Danieli GA, Ramazzo A, Corrado D, Nava A. Arrhythmogenic right ventricular cardiomyopathy: a still underrecognized clinical entity. Trends Cardiovasc Med 1997;7:84-90.
170. Thiene G, Corrado D, Nava A, Rossi L, Poletti A, Boffa GM, Daliento L, Pennelli N. Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? Eur Heart J 1991;12:Suppl D:22-5.
171. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
172. Tiso N, Stephan, DA, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriamo M, Basso C, Thiene G, Danieli GA, Ramazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001;10:189-94.
173. Towbin JA, Ackermann MJ. Cardiac sodium channel gene mutations and sudden infant death syndrome. Confirmation of proof of concept? Circulation 2001;104:1092-3.
174. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1996;269:92-5.
175. Tyson J, Tranebjaerg L, Bellman S, Wren C, Taylor JF, Bathen J, Aslaksen B, Sorland SJ, Lund O, Malcolm S, Pembrey M, Bhattacharya S, Bitner-Glindzicz M. IsKand KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet 1997;6:2179-85.
176. Uhl HS. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hosp 1972;91:197-204.
177. Valente M, Calabrese F, Thiene G, Angelini A, Basso C, Nava A, Rossi L. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol 1998;152:479-84.
178. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 1990;120:661-71.
179. Viskin S, Belhassen B. Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy. Prog Cardiovasc Dis 1998;41:17-34.
180. Viskin S, Lesh MD, Eldar M, Fish R, Setbon I, Laniado S, Belhassen B. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 1997;8: 1115-20.
181. Wang DW, Yazawa K, George ALJ, Bennett PB. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci U S A 1996;93:13200-5.
182. Wang DW, Yazawa K, Makita N, George ALJ, Bennett PB. Pharmacological targeting of long QT mutant sodium channels. J Clin Invest 1997;99:1714-20.
183. Wang Q, Curren ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12: 17-23.
184. Wang Q, Shen J, Li Z, Timothy K, Vincent GM, Priori SG, Schwartz PJ, Keating MT. Cardiac sodium channel mutations in patients with long QT syndrome an inherited cardiac arrhythmia. Hum Mol Genet 1995;4:1603-7.
185. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia long QT syndrome. Cell 1995;80:805-11.
186. Wedekind H, Smits JP, Schulze-Bahr E, Arnold R, Veldkamp MW, Bajanowski T, Borggrefe M, Brinkmann B, Warnecke I, Funke H, Bhuiyan ZA, Wilde AA, Breithardt G, Haverkamp W. A de-novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 2001;104:1158-64.
187. Weiss R, Barmada M, Nguyen T, Seibel JS, Cavlovich D, Kornblit CA, Angelilli A, Villanueva F, McNamara DM, London B. Clinical and molecular heterogeneity in the Brugada syndrome. A novel gene locus on chromosome 3. Circulation 2002;105:707-13.
188. Wichter T, Borggrefe M, Breithardt G. Arrhythmogene rechtsventrikuläre Kardiomyopathie: Ätiologie, Diagnostik und Therapie. Med Klin 1998;93:268-77.
189. Wichter T, Borggrefe M, Breithardt G. How to diagnose and manage right ventricular cardiomyopathy today. In: Raviele A, ed. Cardiac arrhythmias 1997. Milano: Springer, 1998:313-22.
190. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992;86:29-37.
191. Wichter T, Breithardt G, Borggrefe M. Ventricular tachycardia in the normal heart. In: Podrid PJ, Kowey PR, eds.. Cardiac arrhythmias: mechanisms, diagnosis and management. Baltimore: Williams & Wilkins, 1995:1219-38.
192. Wichter T, Gunia S, Brunn J, Hammel D, Borggrefe M, Böcker D. Idiopathic ventricular fibrillation: is ICD-implantation the treatment of choice? Circulation 2000;102:Suppl 11:11-528.
193. 123l-meta-iodobenzylguanidine scintigraphy. Circulation 1994;89:667-83.
194. Wichter T, Matheja P, Borggrefe M, Schäfers K, Haverkamp W, Eckardt L, Schulze-Bahr E, Schober O, Breithardt G. Schäfers M. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 2002;105:702-6.
195. Wichter T, Schäfers M, Borggrefe M, Rhodes CG, Lerch H, Lammertsma AA, Hermansen F, Schober O, Breithardt G, Camici PG. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine re-uptake and postsynaptic β-adrenoceptor density using positron emission tomography. Circulation 2000;101:1552-8.
196. Wollnik B, Schroeder BC, Kubisch C, Esperer HD, Wieacker P, Jentsch TJ. Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet 1997;6:1943-9.
197. Wong ML, Ong CN, Tan TC, Phua KH, Goh LG, Koh K, Lee HP, Chawalit S, Orapun M. Sudden unexplained death syndrome: a review and update. Trop Geogr Med 1992;44:S1-19.
198. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ, International Long-QT Syndrome Registry Research Group. Influence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med 1998;339:960-5.
199. Zhurinsky J, Shtutman M, Ben-Ze'ev A. Plakoglobin and β-catenin: protein interactions, regulation and biological roles. J Cell Sci 2000;113:3127-39.